Novartis Investigative Site

Urayasu, Chiba 279-0021

1 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria, Non-segmental Vitiligo

Studies at this site

• A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo — Recruiting now
• An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib — Running, not enrolling